Think Pink During Breast Cancer Awareness Month
Just like a butterfly, cancer patients can experience various forms of change throughout their treatment. Onco360 understands this transformation and is right alongside you as you spread your wings throughout your journey. During Breast Cancer Awareness Month, and all year long, we provide personalized services, expert clinical care, and the most compassionate care possible for breast cancer patients.
Facts About Breast Cancer
Breast cancer accounts for about 30% (or 1 in 3) of all new cancer diagnosed in the United States, making it the second most common cancer for women.1 The American Cancer Society estimates that about 298,000 new cases of invasive breast cancer will be diagnosed in women in 2023, which equates to about 13% or 1 in 8, with a median age of diagnosis at 62.
Breast cancer also occurs in men but is less common. A lifetime risk is about 1 in 833. It is estimated that in 2023, about 2,800 new cases of invasive breast cancer will be diagnosed in men in the United States.
Risk Factors
- Inheriting certain mutations of the BRCA1 and BRCA2 gene
- Family history
- Race and ethnicity
- Certain benign breast conditions such as fibrosis or mild hyperplasia
- Obesity
- Lack of exercise
Onco360 dispenses these medications to treat breast cancer.
****This list is a small portion of the comprehensive medications Onco360 can provide
Adriamycin® (doxorubicin)
Adrucil® (fluorouracil)
Afinitor® (everolimus)
Aromasin® (exemestane)
Arimidex® (anastrozole)
Cytoxan® (cyclophosphamide)
Doxil® (liposomal doxorubicin)
Ellence® (epirubicin)
Enhertu® (fam-trastuzumab deruxtecan)
Faslodex® (fulvestrant)
Femara® (letrozole)
Gemzar® (gemcitabine)
Halaven® (eribulin)
Herceptin® (trastuzumab)
Herceptin Hylecta™ (trastuzumab, hyaluronidase)
Herzuma® (trastuzumab biosimilar)
Ibrance® (palbociclib)
Ixempra® (ixabepilone)
Jemperli (dostarlimab)
Kadcyla® (ado-trastuzumab emtansine)
Kanjinti® (trastuzumab biosimilar)
Keytruda® (pembrolizumab)
Kisqali® (ribociclib)
Megace® (megestrol acetate)
Navelbine® (vinorelbine)
Nerlynx® (neratinib)
Ogivri® (Trastuzumab biosimilar)
Ontruzant® (trastuzumab biosimilar)
Orserdu™ (elacestrant)
Paraplatin® (carboplatin)
Perjeta® (pertuzumab)
Phesgo® (pertuzumab, trastuzumab, hyaluronidase)
Piqray® (alpelisib)
Platinol® (cisplatin)
Retevmo® (selpercatinib)
Rozlytrek® (entrectinib)
Soltamox® (tamoxifen)
Talzenna® (talazoparib)
Taxol® (paclitaxel)
Taxotere® (docetaxel)
Trazimera® (trastuzumab biosimilar)
Trexall® (methotrexate)
Tukysa® (tucatinib)
Tykerb® (lapatinib)
Verzenio® (abemaciclib)
Xeloda® (capecitabine)
If you are a provider and would like to refer to Onco360, click below
CLICK HERE
Providing Hope Through the National Breast Cancer Foundation, Inc.®
We have partnered with the National Breast Cancer Foundation to bring HOPE to breast cancer patients in honor of Breast Cancer Awareness Month. NBCF creates and distributes HOPE Kits to breast cancer patients that are filled with thoughtful items that are comforting and encouraging. Because our mission is to improve the lives of patients battling cancer, we have sponsored 400 HOPE Kits to be distributed during the month of October.
To find out more about the
National Breast Cancer Foundation or HOPE Kits
Helpful Resources:
National Breast Cancer Foundation
1Key Statistics for Breast Cancer. Accessed 8/23.
https://www.cancer.org/cancer/types/breast-cancer/about/how-common-is-breast-cancer.html
https://www.cancer.org/cancer/types/breast-cancer-in-men/causes-risks-prevention/risk-factors.html
*2023 nomination by MMIT in the Independent Specialty Pharmacy category. MMITnetwork.com